PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 25.6 EUR 1.59%
Market Cap: 306.9m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

PharmaSGP Holding SE
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Net Income Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Net Income
€16.4m
CAGR 3-Years
16%
CAGR 5-Years
2%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Net Income
-$43.9m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Net Income
-€1.3B
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Net Income
€2.6B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
8%
MPH Health Care AG
XETRA:93M1
Net Income
€29.5m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Net Income
€129.8m
CAGR 3-Years
-10%
CAGR 5-Years
11%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Net Income?
Net Income
16.4m EUR

Based on the financial report for Dec 31, 2023, PharmaSGP Holding SE's Net Income amounts to 16.4m EUR.

What is PharmaSGP Holding SE's Net Income growth rate?
Net Income CAGR 5Y
2%

Over the last year, the Net Income growth was 37%. The average annual Net Income growth rates for PharmaSGP Holding SE have been 16% over the past three years , 2% over the past five years .

Back to Top